Outlook Therapeutics (OTLK) Tax Rate (2015 - 2025)

Outlook Therapeutics (OTLK) posted quarterly Tax Rate of 10.49% for Q3 2025, up 173756.44% quarter-over-quarter from 0.01% in Q1 2025.

Outlook Therapeutics (OTLK) Tax Rate (2015 - 2025) Analysis & Trends

Outlook Therapeutics (OTLK) has reported Tax Rate for 11 consecutive years, with 10.49% the latest figure, recorded in Q3 2025.

In Q3 2025, Tax Rate changed N/A year-over-year to 10.49%; the TTM figure through Sep 2025 stood at 1.51% (up 151.0% YoY), while the FY2025 annual figure was 2.43%, up 243.0% from the prior year.
Tax Rate advanced to 10.49% in Q3 2025 per OTLK's latest filing, from 0.01% in the prior quarter.
Across five years, Tax Rate topped out at 10.49% in Q3 2025 and bottomed at 0.04% in Q1 2023.
Historically, Tax Rate has averaged 1.49% across 5 years, with a median of 0.01% in 2025.
Annual changes were most pronounced in 2023 — Tax Rate declined 3 bps — and 2024, when it grew 4 bps.
Outlook Therapeutics' Tax Rate stood at 0.02% in 2021, then jumped by 63 bps to 0.01% in 2022, then tumbled by 655 bps to 0.04% in 2023, then surged by 94 bps to 0.0% in 2024, then jumped by 428248 bps to 10.49% in 2025.
Business Quant data shows OTLK's Tax Rate at 10.49% in Q3 2025, 0.01% in Q1 2025, and 0.0% in Q1 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	15.11%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	10.91%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	34.12%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Outlook Therapeutics	88.50 Mn	77.26 Mn	-8,265.00	-

Download Data